Skip to main content

Chikungunya vaccine, recombinant (cvx 329) Disease Interactions

There is 1 disease interaction with chikungunya vaccine, recombinant (cvx 329).

Moderate

Vaccines (inactivated)/toxoids (applies to chikungunya vaccine, recombinant (cvx 329)) immunodeficiency

Moderate Potential Hazard, Moderate plausibility.

The expected serum antibody responses may not be obtained when vaccines and/or toxoids are administered to patients with primary or acquired immunodeficiency, including those with severe combined immunodeficiency, hypogammaglobulinemia or agammaglobulinemia, HIV infection, altered immune states (due to diseases such as leukemia, lymphoma, or generalized malignancy), or immunosuppression due to drug or other treatments (e.g., corticosteroids, alkylating agents, antimetabolites, or radiation).

Switch to professional interaction data

Chikungunya vaccine, recombinant (cvx 329) drug interactions

There are 298 drug interactions with chikungunya vaccine, recombinant (cvx 329).

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer